BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1413493)

  • 21. p53 accumulation in ovarian carcinomas and its prognostic implications.
    Bosari S; Viale G; Radaelli U; Bossi P; Bonoldi E; Coggi G
    Hum Pathol; 1993 Nov; 24(11):1175-9. PubMed ID: 8244317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.
    Isola J; Visakorpi T; Holli K; Kallioniemi OP
    J Natl Cancer Inst; 1992 Jul; 84(14):1109-14. PubMed ID: 1352359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between ploidy status, Erb-B2 and p53 immunohistochemical expression in primary breast carcinoma.
    Midulla C; Giovagnoli MR; Valli C; Vecchione A
    Anal Quant Cytol Histol; 1995 Jun; 17(3):157-62. PubMed ID: 7546049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme-linked immunoabsorbent assay-detected p53 protein accumulation: a prognostic factor in a large breast cancer cohort.
    Levesque MA; Yu H; Clark GM; Diamandis EP
    J Clin Oncol; 1998 Aug; 16(8):2641-50. PubMed ID: 9704714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancer.
    O'Malley FP; Saad Z; Kerkvliet N; Doig G; Stitt L; Ainsworth P; Hundal H; Chambers AF; Turnbull DI; Bramwell V
    Hum Pathol; 1996 Sep; 27(9):955-63. PubMed ID: 8816892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
    Gasparini G; Weidner N; Bevilacqua P; Maluta S; Dalla Palma P; Caffo O; Barbareschi M; Boracchi P; Marubini E; Pozza F
    J Clin Oncol; 1994 Mar; 12(3):454-66. PubMed ID: 7509851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density.
    Mandard AM; Denoux Y; Herlin P; Duigou F; van De Vijver MJ; Clahsen PC; van Den Broek L; Sahmoud TM; Henry-Amar M; van De Velde CJ
    Cancer; 2000 Oct; 89(8):1748-57. PubMed ID: 11042570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
    Turner BC; Gumbs AA; Carbone CJ; Carter D; Glazer PM; Haffty BG
    Cancer; 2000 Mar; 88(5):1091-8. PubMed ID: 10699900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.
    Silvestrini R; Veneroni S; Daidone MG; Benini E; Boracchi P; Mezzetti M; Di Fronzo G; Rilke F; Veronesi U
    J Natl Cancer Inst; 1994 Apr; 86(7):499-504. PubMed ID: 8133533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of p53 and Ki67 in Paget's disease of the vulva and the breast.
    Ellis PE; Fong LF; Rolfe KJ; Crow JC; Reid WM; Davidson T; MacLean AB; Perrett CW
    Gynecol Oncol; 2002 Aug; 86(2):150-6. PubMed ID: 12144821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic relevance of p53 in node negative breast cancer.
    Kristen P; Müller JG; Caffier H
    Anticancer Res; 1997; 17(4B):2869-71. PubMed ID: 9329550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 quantitative immunocytochemical analysis in breast carcinomas.
    Charpin C; DeVictor B; Andrac L; Amabile J; Bergeret D; LaVaut MN; Allasia C; Piana L
    Hum Pathol; 1995 Feb; 26(2):159-66. PubMed ID: 7860046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic value of p53 immunostaining in node-negative breast carcinoma.
    Soontrapornchai P; Chanvitan A; Koontongkaew S; Sunpaweravong S
    J Med Assoc Thai; 2007 Sep; 90(9):1833-8. PubMed ID: 17957927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 protein expression in breast cancer as related to histopathological characteristics and prognosis.
    Lipponen P; Ji H; Aaltomaa S; Syrjänen S; Syrjänen K
    Int J Cancer; 1993 Aug; 55(1):51-6. PubMed ID: 8344753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE; André S; Soares J
    J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer.
    Silvestrini R; Veneroni S; Benini E; Daidone MG; Luisi A; Leutner M; Maucione A; Kenda R; Zucali R; Veronesi U
    J Natl Cancer Inst; 1997 May; 89(9):639-45. PubMed ID: 9150188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors.
    Günther T; Schneider-Stock R; Rys J; Niezabitowski A; Roessner A
    J Cancer Res Clin Oncol; 1997; 123(7):388-94. PubMed ID: 9260591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival.
    Barbareschi M; Caffo O; Doglioni C; Fina P; Marchetti A; Buttitta F; Leek R; Morelli L; Leonardi E; Bevilacqua G; Dalla Palma P; Harris AL
    Br J Cancer; 1996 Jul; 74(2):208-15. PubMed ID: 8688323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.